Clinical Trial Update: Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2 [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating Hepatitis A vaccination in HIV-infected individuals with an adjuvant Interleukin-2. The current status of the trial is li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis A
• Hepatitis B

Drugs mentioned

• Hepatitis A vaccine (inactivated Hepatitis A vaccine)
• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Aalborg University Hospital | Conditions: HIV Infections, Hepatitis A | Phase 3 | Status: UNKNOWN